Article Versions Notes

Verkhovskaia S, Falcone R, Di Pietro FR, Carbone ML, Samela T, Perez M, Poti G, Morelli MF, Zappalà AR, Di Rocco ZC, et al. Survival of Patients with Metastatic Melanoma Treated with Ipilimumab after PD-1 Inhibitors: A Single-Center Real-World Study. Cancers. 2024; 16(19):3397. https://doi.org/10.3390/cancers16193397

Verkhovskaia, Sofia, Rosa Falcone, Francesca Romana Di Pietro, Maria Luigia Carbone, Tonia Samela, Marie Perez, Giulia Poti, Maria Francesca Morelli, Albina Rita Zappalà, Zorika Christiana Di Rocco, and et al. 2024. "Survival of Patients with Metastatic Melanoma Treated with Ipilimumab after PD-1 Inhibitors: A Single-Center Real-World Study" Cancers 16, no. 19: 3397. https://doi.org/10.3390/cancers16193397

Verkhovskaia, S., Falcone, R., Di Pietro, F. R., Carbone, M. L., Samela, T., Perez, M., Poti, G., Morelli, M. F., Zappalà, A. R., Di Rocco, Z. C., Morese, R., Piesco, G., Chesi, P., Marchetti, P., Abeni, D., Failla, C. M., & De Galitiis, F. (2024). Survival of Patients with Metastatic Melanoma Treated with Ipilimumab after PD-1 Inhibitors: A Single-Center Real-World Study. Cancers, 16(19), 3397. https://doi.org/10.3390/cancers16193397